Navigation Links
Vakzine Projekt Management Reports Positive Clinical Trial Results,With Their Therapeutic Prostate Cancer Vaccine VPM4001

HANOVER, Germany--(BUSINESS WIRE)--Jun 1, 2007 - A therapeutic vaccine developed by the German company VPM to battle prostate cancer promises new hope for cancer patients. The results of a successfully completed clinical study will be presented to an international audience at the Annual Conference of the American Society for Clinical Oncology (ASCO) in Chicago, USA. ASCO is the most important professional organization of cancer specialists world-wide.

The active substance VPM4001, an immunotherapeutic for cancer treatment, has reached an important stage of development: A clinical phase I/II study with 30 patients successfully completed in 2006 showed that 73 % of patients suffering from advanced, hormone-resistant prostate carcinoma responded positively to the VPM4001 therapy. The primary study parameter, the PSA doubling time, was increased from 63 days to 114 days on average. This promising result has a high statistical significance (p=0.0035). VPM4001 also showed an excellent tolerability profile. The study was carried out at the Institute for Experimental Oncology (Prof. Dr. med. B. Gansbacher) and at the Clinic for Urology (Prof. Dr. med. R. Hartung) of Munich Technical University.

The new vaccine will support the immune system to fight cancer. Based on the promising results, a panel of international experts from the USA, Germany and the Netherlands has recommended the continuation of clinical development of the vaccine as fast as possible. Prostate cancer is the most frequent type of tumor affecting male patients aged 50+ and also the third most frequent cause of death resulting from cancer disease. Each year approx. 420,000 people in Europe and in the USA are affected by prostate cancer. The life-time risk of becoming affected by prostate cancer is 1:6.

VPM4001 is an ideal example for the development of innovative vaccines initiated by VPM. This has lead to the development project being int
'"/>




Page: 1 2

Related medicine technology :

1. Choosing Lab Quality Management Software
2. Optimizing Quality Control Data Management
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07 Teleconference to Answer Questions About TA-65, Their Telomerase Activator With Proven Age Management Benefits
5. Oculus Innovative Sciences Microcyn Technology Presented in Poster at European Wound Management Association Conference
6. Weight Management is Not Enough for Cannabinoid Type 1 (CB1) Receptor Antagonists to Become a Commercial Success
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
11. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
Post Your Comments:
(Date:6/29/2015)... 2015  PDL BioPharma, Inc. (NASDAQ: PDLI ) ... agreement with CareView Communications, Inc. (OTCQB: CRVW) whereby PDL ... secured debt financing. CareView is an information technology provider ... Under the credit agreement, PDL will provide ... in two tranches of $20 million, based upon the ...
(Date:6/29/2015)... , June 29, 2015  Allergan plc ... intends to release second quarter 2015 financial results ... open of the U.S. financial markets. The Company will ... a.m. Eastern Daylight Time on Thursday, August 6, ... to access the call is U.S./ Canada ...
(Date:6/29/2015)... TARRYTOWN, N.Y. , June 29, 2015 /PRNewswire/ ... today announced that the Proceedings of the ... a paper demonstrating that the Company,s proprietary VelociGene ... the rapid identification and preclinical validation of potential ... and treatment of Middle East Respiratory Syndrome (MERS). ...
Breaking Medicine Technology:PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 2PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 3PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 4Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast 2Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast 3Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 2Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 3Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 4Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 5
... DURHAM, N.C., May 1, 2012 Heart IT, ... approved zero footprint medical imaging workstation, WebPAX®, announced ... "zero-footprint" medical image viewing technologies. "Zero-footprint" technologies allow ... any computing platform with a standard Internet web ...
... 2012 Amarantus BioSciences, Inc. (OTCBB: AMBS), a ... the treatment of Parkinson,s disease and other nervous ... selected to present in the Emerging Companies Showcase ... Meeting on May 2nd, 2012 in New York ...
Cached Medicine Technology:U.S. Patent Office Issues Sixth Patent Covering 'Zero-Footprint' Medical Image Viewers to Heart Imaging Technologies, LLC 2Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012 2Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012 3
(Date:6/30/2015)... GA (PRWEB) , ... June 30, 2015 , ... ... achievements of aspiring data scientists and analysts who are currently attending an accredited ... the growth of data has provided new insight into healthcare, the environment, political ...
(Date:6/30/2015)... ... June 30, 2015 , ... Americans report feeling more ... buzzer on Monday mornings, which puts stressed out people right over the edge. ... 22% suffering from sleep deprivation every night. Sleeping pills now lead the list of ...
(Date:6/30/2015)... ... , ... Scott Purdy, the spokesperson for Dephinitive Systems LLC, announces today that ... the XO stands for eXtra Operability (XO) which was chosen to reflect the company’s ... Cycle. , Provider XO, based in Cleveland OH, is part of the Cadrillion ...
(Date:6/30/2015)... ... June 30, 2015 , ... “It is never too early ... “We are particularly interested in getting the word out to children because sun ... We are extremely pleased with our new video which we feel is ...
(Date:6/29/2015)... St. Petersburg, FL (PRWEB) , ... June 30, 2015 , ... ... with a special 50% Off offer. The oil, ideal for natural skincare and ... a natural and easy way is something most people desire, and Oil Pulling can ...
Breaking Medicine News(10 mins):Health News:Izenda Offers Embedded BI and Analytics Scholarship 2Health News:Izenda Offers Embedded BI and Analytics Scholarship 3Health News:Wake UP Happy and Sleep Soundly with Famous Experts with My Wake UP Call® Motivational Alarm Clock® Messages and My Good Night Messages™ - Now Available at Audible! 2Health News:Wake UP Happy and Sleep Soundly with Famous Experts with My Wake UP Call® Motivational Alarm Clock® Messages and My Good Night Messages™ - Now Available at Audible! 3Health News:Dephinitive Systems Is Getting a New Name 2Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Joins Effort to Promote Sun Safety 2Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Joins Effort to Promote Sun Safety 3Health News:New Product: Transform Wellness and Oral Health With This Ancient Ayurvedic Secret and Organic Product from Sublime Beauty NATURALS® 2
... data security set foundation for future systems, ... Committee of,Massachusetts, Inc. (AAC) commends state lawmakers ... security protections within a statewide,electronic medical records ... information, providing patients an audit trail of ...
... parents encourage the habit, U.S. survey shows , , MONDAY, Aug. ... are getting early and regular exposure to violent movies, a ... percent of the nation,s estimated 22 million children between the ... of violence in film, whether in theaters, on DVDs, or ...
... When community leaders brainstorm ways to improve the health ... brings together doctors and health care professionals, hospitals, public ... are another key player in the fight against childhood ... report. , "Community recreation and parks is the health ...
... the International Journal of Hematology by scientists from ... Fudan University, Shanghai, in collaboration with the ... that specific subtypes of chronic lymphoid neoplasms are ... previously reported. Diagnosis and classification were performed by ...
... new study from researchers at the American Cancer ... alternative methods, most often prayer, relaxation, supplements, meditation, ... such as biofeedback, homeopathy, and acupressure, are relatively ... Society peer review journal CANCER, also ...
... today, Goshen Scout Reservation has been closed and will,remain ... Area,Council (NCAC), BSA was made aware of three additional ... affected Scouts were,at Goshen Scout Reservation during week 5 ... of the bacteria remains unconfirmed. There were 1,310,Scouts, adult ...
Cached Medicine News:Health News:AIDS Action Committee Applauds Legislature for Taking Action to Protect Patient Privacy Within New Electronic Medical Records System 2Health News:Many Kids Under 15 Watch Violent Movies 2Health News:Many Kids Under 15 Watch Violent Movies 3Health News:Recreation and park agencies play a key role in promoting healthy lifestyles 2Health News:Fudan-Cinpathogen Study Shows Chronic Lymphoid Neoplasms are More Common in Shanghai Than Thought 2Health News:American Cancer Society study finds high use of complementary methods among cancer survivors 2
... headboxes are the latest ... of portable battery-powered EEG ... robust new mechanical design, ... XLTEK's standard MOBEE24plus and ...
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
Medicine Products: